Long-term follow-up of AGN1 hip treatment
Part of Bones, joints & muscles, Genetic & congenital, Hormones & metabolism, Injuries & trauma, Skin clinical trials.
This study looks back at people who had a special hip treatment called AGN1 LOEP to see how they are doing over time. It helps doctors learn more about the treatment's safety and how well it works.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You had the AGN1 LOEP treatment on your upper thigh bone (near the hip) after September 2019.
- You had the treatment before January 2026.
- You can agree to let the researchers collect your health information.
- This study is for people who are alive and can give permission, but it also includes some people who have passed away.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies AGN1 LOEP, a treatment being tested to improve bone strength in people with osteoporosis-related bone loss in the hip. If you qualify, you would be followed over time with clinic visits and testing to see how the treatment affects your bone health.
This trial tests AGN1 LOEP (a medicine/device placed at the hip surgery site) to help prevent another hip fracture after you’ve had a low-energy hip fracture. You must be eligible for hip repair surgery and be at higher risk for another fracture, with no key exclusions like active cancer or serious kidney disease.
This study follows patients who have had a complex hip replacement to see how they do over time. It may help if your hip surgery was more complicated than usual, such as after prior surgeries, injuries, or certain medical conditions.
This is an observational study that follows people over time after hip hemiarthroplasty (a partial hip replacement). It aims to understand how well Corin hip devices work long-term in everyday care, and what outcomes to expect.
This study checks how well a particular hip replacement stem (the PROFEMUR Preserve Classic Femoral Stem) and matching parts keep working over many years. You may be invited if you had that exact hip replacement combination and can return for long-term checkups.
This study checks how well a specific hip replacement bearing surface (called dual mobility with Vivacit-E or Longevity) performs over time in real-world patients. It may help people by tracking long-term safety and performance to guide better hip replacement choices.
Hear when a new Osteoporosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.